ZyVersa Therapeutics Gestion
Gestion contrôle des critères 1/4
ZyVersa Therapeutics' CEO is Steve Glover, appointed in Dec 2022, has a tenure of 1.92 years. total yearly compensation is $993.22K, comprised of 55.4% salary and 44.6% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth $2.74K. The average tenure of the management team and the board of directors is 1.9 years and 1.9 years respectively.
Informations clés
Steve Glover
Directeur général
US$993.2k
Rémunération totale
| Pourcentage du salaire du PDG | 55.4% |
| Durée du mandat du directeur général | 1.9yrs |
| Propriété du PDG | 0.1% |
| Durée moyenne d'occupation des postes de direction | 1.9yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 1.9yrs |
Mises à jour récentes de la gestion
Recent updates
Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$22m |
| Mar 31 2024 | n/a | n/a | -US$106m |
| Dec 31 2023 | US$993k | US$550k | -US$106m |
| Sep 30 2023 | n/a | n/a | -US$88m |
| Jun 30 2023 | n/a | n/a | -US$98m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$1m | US$451k | -US$14m |
| Sep 30 2022 | n/a | n/a | -US$21m |
| Jun 30 2022 | n/a | n/a | -US$10m |
| Mar 31 2022 | n/a | n/a | -US$10m |
| Dec 31 2021 | US$2m | US$451k | -US$8m |
| Dec 31 2020 | US$451k | US$451k | -US$13m |
Rémunération vs marché: Steve's total compensation ($USD993.22K) is above average for companies of similar size in the US market ($USD655.65K).
Rémunération et revenus: Steve's compensation has been consistent with company performance over the past year.
PDG
Steve Glover (64 yo)
1.9yrs
Titularisation
US$993,217
Compensation
Mr. Stephen C. Glover, also known as Steve, serves as Chairman of the Board at Ambrx Biopharma Inc. since May 18, 2023. He has been a Director of Incon Co., Ltd. since December 2018.Mr. Glover is a Co-Fou...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Co-Founder | 1.9yrs | US$993.22k | 0.13% $ 2.7k | |
| CFO & Secretary | 1.9yrs | US$573.36k | 0.012% $ 244.6 | |
| Chief Commercial Officer | 1.9yrs | US$486.69k | 0% $ 0 | |
| Senior Vice President of Corporate Development | no data | pas de données | pas de données | |
| Chief Medical Officer | 1.8yrs | pas de données | 0.0071% $ 145.3 |
1.9yrs
Durée moyenne de l'emploi
68yo
Âge moyen
Gestion expérimentée: ZVSA's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Co-Founder | 1.9yrs | US$993.22k | 0.13% $ 2.7k | |
| Chief Medical Officer | no data | pas de données | 0.0071% $ 145.3 | |
| Independent Director | 1.8yrs | US$80.14k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$80.64k | 0% $ 0 | |
| Independent Director | 1.8yrs | US$72.90k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Independent Director | 1.9yrs | US$66.39k | 0% $ 0 |
1.9yrs
Durée moyenne de l'emploi
63yo
Âge moyen
Conseil d'administration expérimenté: ZVSA's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.